Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed
Osteoarthritis and Cartilage , 07/01/09
Graverand-Gastineau MPHL et al. - The development of symptom modifying OA drug is exploding with a plethora of pain pathways being pursued and multiple candidates in advanced stages of clinical development. Structure modification in OA remains complex with significant development challenges.
Related Articles
There Is Inadequate Evidence to Determine the Effectiveness of Nonpharmacological and Nonsurgical Interventions for Hand Osteoarthritis: An Overview of High-Quality Systematic Reviews
Physical Therapy, 11/10/09
Relevance Score: 90%
The Safety of Flavocoxid, a Medical Food, in the Dietary Management of Knee Osteoarthritis
Journal of Medicinal Food, 10/30/09
Relevance Score: 89%
Discriminant Validity of the Western Ontario and McMaster Universities Osteoarthritis Index Physical Functioning Subscale in Community Samples With Hip Osteoarthritis
Archives of Physical Medicine and Rehabilitation, 10/22/09
Relevance Score: 89%
Clinical efficacy evaluation on electroacupuncture for osteoarthritis and observation on biomechanical indexes
Journal of Acupuncture and Tuina Science, 10/19/09
Relevance Score: 89%
Effect of nonsteroidal anti-inflammatory drug plasters for knee osteoarthritis in Japanese: a randomized controlled trial
Modern Rheumatology, 10/12/09
Relevance Score: 89%
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study
Pain Medicine, 12/10/09
Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program?
Pain Research and Management, 12/10/09
Alendronate reduces osteoclast precursors in osteoporosis
Osteoporosis International, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


